This bill adds a new section to the Internal Revenue Code that lets people who donate life-saving organs claim a federal tax credit to cover a range of donation-related expenses. It also amends the Public Health Service Act and the National Organ Transplant Act to coordinate federal donor grants and to clarify that the credit is not unlawful compensation under transplant law.
The change aims to reduce financial barriers to living organ donation by making direct outlays — travel, medical follow-up, paperwork and lost wages — tax-eligible. The bill raises implementation questions for tax and transplant administrators about verification, overlap with reimbursements, and how the credit will interact with existing donor-support programs.
At a Glance
What It Does
The bill creates a federal tax credit that allows an individual donor to recover specified donation-related expenses by claiming them on their federal return. Eligible categories include transaction costs, travel and lodging, donation-related medical and follow-up care, legal or paperwork fees, and wages lost because of the donation.
Who It Affects
Directly affected parties include living organ donors, transplant centers and hospital billing offices (which will need to document removals and costs), and the IRS (which will administer and verify claims). Federal grant programs that fund donor support will need to coordinate eligibility and payment with the new tax treatment.
Why It Matters
This is a policy-level shift that uses the tax code to subsidize individual donors rather than routing money solely through grants or hospital programs. It could lower the out-of-pocket cost of donation, change how hospitals counsel donors, and create new administrative work for tax and health regulators.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill inserts a new section into the Internal Revenue Code that lets a person who gives an organ for transplantation claim donation expenses on their federal tax filing. The statutory wording ties the claim to an actual removal event, requires the transplant to occur under U.S. law, and excludes any amounts already reimbursed by other sources — so donors cannot double-claim costs that someone else already paid.
Eligibility hinges on three practical verifications: that an organ was removed from an individual who was alive at removal, that the transplantation occurred in the United States according to applicable law, and that the donor's claimed amounts are not reimbursed elsewhere. The bill gives the IRS the role of allowing the credit on the tax return, which means transplant hospitals and payers will likely have to provide documentation or attestations to support donor claims.Separately the bill tweaks two non-tax statutes.
It amends the Public Health Service Act language governing federal living donation grants so that grant administrators consider whether a donor has received or expects to receive this tax relief. It also amends the National Organ Transplant Act to insert the tax credit expressly into the list of items that are not treated as unlawful compensation — a legal safeguard designed to reduce the risk that payments to donors would be treated as illegal inducements.Finally, the bill includes a short sequence of conforming and clerical changes to federal administrative code sections and sets differing effective dates for tax-code changes and the statutory amendments to the Public Health Service Act and the National Organ Transplant Act.
Those timing details matter for when donors and grant administrators begin to coordinate benefits.
The Five Things You Need to Know
The bill describes the tax change as a refundable credit permitting donors to claim donation-related costs on their federal return.
The credit excludes any amounts that have already been reimbursed by another person or entity, public or private.
The statute lists eligible organs explicitly: kidney, liver, lung, pancreas, intestine, bone marrow, or any part thereof.
The credit applies only where the donor is alive at the time the organ is removed (i.e.
living donors).
The statute caps the credit at $5,000 per individual for any taxable year.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Gives the act its public name, the "Living Organ Donor Tax Credit Act." This is purely stylistic but signals Congress' intent to frame the measure as donor support rather than a broader transplant financing reform.
Scope of the tax credit and covered expense categories
Adds a new Internal Revenue Code section that permits individuals who donate a qualifying organ to claim certain categories of donation-related outlays on their federal return. The provision enumerates covered categories — transaction costs, travel and lodging, medical and follow-up care, paperwork/legal fees, and lost wages — which sets a broad baseline for what donors can try to recover through the tax system. Because the statute ties the benefit to specific expense types rather than a flat amount alone, documentation and classification of expenses will drive most administrative questions.
Cap, definitions, living donor restriction, and reimbursement exclusion
The law places an absolute per-taxable-year cap on the credit and defines the term "qualified life-saving organ," explicitly listing covered organs. It restricts eligibility to donors who are alive at removal, and it disallows amounts already reimbursed. Those definitional and limitation rules are practical gatekeepers: the living-donor requirement excludes deceased donation events, and the reimbursement exclusion prevents duplicative benefits when employers, insurers, or grants have paid donor costs.
Coordination with existing federal transplant statutes
Amends the Public Health Service Act so that federal grant administrators factor tax-credit receipt or expected receipt into their determination of grant payments. It also amends the National Organ Transplant Act to state explicitly that the tax credit is not "unlawful compensation," reducing legal ambiguity about whether tax relief could be construed as an inducement under transplant criminal statutes. Both changes are administrative fixes intended to align grant practice and criminal statutes with the tax change, but they also create new points of contact between tax administrators and health program officials.
Conforming and clerical amendments
Makes small cross-reference edits in federal collections and bookkeeping statutes to insert the new section number into existing lists. These are technical but necessary so that databases, accounting references, and Treasury tracking include the new credit when agencies run automated checks and reports.
Effective dates
Sets two different effective dates: the tax-code amendments apply to taxable years beginning after enactment, while the Public Health Service Act and National Organ Transplant Act amendments take effect on the date of enactment. That stagger means grant administrators and transplant programs must adjust immediately under the health statutes, but taxpayers will claim the credit only in returns covering later tax years — creating a short transitional window for coordination.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Living organ donors — Reduces net financial burden by allowing donors to recover a range of direct and indirect costs associated with donation, which can make donation feasible for those without employer-paid leave or other supports.
- Transplant recipients and waiting lists — Lower donor financial barriers may modestly increase living-donor supply, improving transplant access for patients with compatible donors.
- Transplant programs and hospitals — May see fewer unpaid bills and better retention of donors through post-donation follow-up when donors can expect tax relief; could also simplify counseling by having a federal tax mechanism to point to.
- Federal grant administrators (HRSA and related programs) — Gain statutory clarity to coordinate grant disbursements with tax relief, potentially stretching grant dollars further by leveraging tax benefits.
Who Bears the Cost
- Federal taxpayers/general budget — The refundable nature of the credit (as described in the bill header) and the inclusion of lost wages mean the program will have a direct fiscal cost that reduces federal revenue.
- IRS and Treasury — Must build rules, forms, compliance checks, and audit procedures to verify removals, documentation of costs, and absence of reimbursement, increasing administrative workload and enforcement needs.
- Transplant centers and hospitals — Likely to bear increased documentation and attestation duties to verify that an organ was removed and to help donors substantiate eligible costs, imposing operational and compliance costs.
- Employers and insurers — May need to coordinate benefits reporting and address whether employer-paid leave or insurer reimbursements reduce a donor's creditable expenses, complicating payroll and benefits administration.
Key Issues
The Core Tension
The central dilemma is balancing two legitimate goals: making donation financially feasible for individuals (which argues for generous, easy-to-claim support) and avoiding any policy that functions as a payment-for-organs system (which requires tight limits, documentation and anti-inducement safeguards). The bill leans toward donor support, but that choice raises enforcement, ethical, and administrative challenges with no simple technical fix.
The bill creates practical and legal trade-offs that will show up during implementation. First, the statute requires proof that an organ was removed and that the transplant occurred "in accordance with United States law;" the IRS will need procedural authority and clear evidence standards to accept or deny claims.
Hospitals will be the natural source of attestation, but they may resist taking on increased certification liability without funding or legal protections.
Second, the interaction between this credit and other donor-support mechanisms is knotty. The statute excludes reimbursed amounts, but it does not specify how to treat employer-paid sick leave, state leave benefits, or direct grants: must those be subtracted dollar-for-dollar, or treated as separate buckets?
The amendments to the Public Health Service Act direct grant programs to consider tax-credit receipt, but without implementation guidance program officers must make judgment calls that could lead to inconsistent treatment across jurisdictions. Finally, the bill's framing of the credit as "not unlawful compensation" under transplant law reduces legal risk, but courts and prosecutors could still scrutinize cases where payments, benefits or marketing practices around the credit look like inducements.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.